Cartesian Therapeutics, Inc. — Director's Dealing 2019

Aug 16, 2019

SEC Form 4/A — Form 4/A

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-01-25

Reporting Person: Farokhzad Omid (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25626	Indirect
Common Stock	202051	Indirect
Common Stock	188004	Direct

Footnotes

F1: These shares were omitted from the Reporting Person's original Form 4 filed on March 29, 2019.

F2: These securities are held by BioDynamics Core, L.P., which is managed by BioDynamics, LLC, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: These securities are held by SAF-SEL Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.